益生菌作为非传染性胃潰瘍管理的治疗方法:综合性审查
Subhasree Mal1,2, Tridip K Das1,2, Shrabani Pradhan3
1Department of Biological Sciences, Midnapore City College, Midnapore, West Bengal, India.
Probiotics and antimicrobial proteins
|August 27, 2024
概括
益生菌,包括有益的酵母,通过减少炎症和恢复胃内膜平衡,为管理非传染性胃提供了一个有希望的,非侵入性的替代方案. 酵母益生菌特别有利,因为它们对抗生素具有天然的耐药性.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胃是胃内膜的干扰,主要是由Helicobacter pylori感染或NSAID使用引起的.
- 饮酒,吸烟和压力等生活方式因素也可能导致非传染性胃潰瘍.
- 目前的治疗方法面临着抗生素耐药性和副作用等挑战,需要采用替代方法.
研究的目的:
- 审查益生菌的治疗潜力,特别是酵母益生菌,用于管理非传染性胃潰瘍.
- 分析益生菌在治疗胃方面的益处,并将其与传统治疗方法进行比较.
- 突出酵母益生菌的优点,因为它们对抗菌抗生素具有固有的耐药性.
主要方法:
- 对益生菌 (细菌和酵母) 的研究及其在胃管理中的有效性进行了全面的文献综述.
- 分析益生菌发挥作用的机制,包括免疫调节和胃防御因子的恢复.
- 与细菌益生菌相比,酵母益生菌的特异性质的评估.
主要成果:
- 益生菌,包括Lactobacillus,Bifidobacterium和酵母,显示出治疗胃的潜力.
- 益生菌可以通过调节免疫反应,减少炎症,平衡保护性和攻击性胃因子来治愈胃.
- 酵母益生菌具有独特的优势,因为它们对抗菌性抗生素具有天然耐药性,解决了对抗菌素耐药性的担忧.
结论:
- 益生菌是一种可行的,非侵入性的治疗选择,用于非传染性胃潰瘍.
- 在抗生素使用和潜在的耐药性方面,酵母益生菌具有明显的优势.
- 对益生菌应用的进一步研究,特别是基于酵母的疗法,是有效的胃管理的必要条件.
相关概念视频
01:26Peptic Ulcer Disease IV: Management
78
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
78
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
377
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
377
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
335
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
335
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
361
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
361
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
358
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
358
01:30Peptic Ulcer Disease I: Introduction
159
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
159